Antibody Engineering & Therapeutics Europe brings you the latest science, technologies and partners needed to accelerate next generation antibodies towards commercial success.

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy provides targeted peer-reviewed research that advances the understanding of immune responses and the use of immunological methods for therapeutic purposes. Fully refereed, peer-reviewed articles and short communications present current findings in the development and characterization of mAbs across all therapeutic areas. Development of mAbs for all research applications, including probes, inhibitors, and diagnostic reagents, is also described.

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.y, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

Viral Immunology delivers cutting-edge peer-reviewed research on rare, emerging, and under-studied viruses, with special focus on analyzing mutual relationships between external viruses and internal immunity. Original research, reviews, and commentaries on relevant viruses are presented in clinical, translational, and basic science articles for researchers in multiple disciplines.

Pick up your copy of this essential resource at Antibody Engineering & Therapeutics Europe.